Melanoma Model

Immunocytokine augments local and abscopal response and animal survival when added to radiation and CTLA-4 checkpoint inhibition in a murine melanoma model
Zachary S Morris, Emily I Guy, David M Francis, Monica M Gressett, Eric A Armstrong, Shyhmin Huang, Stephen D Gillies, Alan J Korman, Jacquelyn A Hank, Alexander L Rakhmilevich, Paul M Harari, Paul M Sondel

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P308; DOI: 10.1186/2051-1426-3-S2-P308
The A2A adenosine receptor regulates the formation of new lymphatic vessels in inflammatory microenvironments
Bertrand Allard, John Stagg

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P71; DOI: 10.1186/2051-1426-3-S2-P71
Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
Rikke B Holmgaard, Dmitriy Zamarin, David H Munn, Taha Merghoub, Jedd D Wolchok

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P212; DOI: 10.1186/2051-1426-2-S3-P212
Cytomegalovirus containing TRP2 antigen provides protective immunity against the poorly immunogenic B16BL6-D5 melanoma
Michael Neuberger, Shawn M Jensen, Guangwu Xu, Tameka Smith, Hong-Ming Hu, Ann B Hill, Carlo B Bifulco, Bernard A Fox

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P271; DOI: 10.1186/2051-1426-1-S1-P271
Role of dose selection in successful interleukin-2 immunotherapy: solving the Goldilock’s Complex
Andrew Zloza, Joseph R Broucek, Erica J Huelsmann, Tasha Hughes, Howard L Kaufman

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P266; DOI: 10.1186/2051-1426-1-S1-P266
Dendritic cells inhibit myeloid-derived suppressor cells infiltration and function in mouse B16 melanoma microenvironment
Siyuan Xia, Jun Wei, Jingya Wang, Liqing Zhao, Zhinan Yin

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P195; DOI: 10.1186/2051-1426-1-S1-P195

Log in using your username and password

Main menu

Log in using your username and password

You are here

Melanoma Model